European cardiology最新文献_第8页

Young Investigator Award: Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice. 青年研究者奖:复方A，生姜提取物，显著减少压力过载引起的小鼠收缩期心力衰竭。

IF 3

European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO1

Yuto Kawase, Kana Shimizu, Masafumi Funamoto, Yoichi Sunagawa, Yasufumi Katanasaka, Yusuke Miyazaki, Satoshi Shimizu, Koji Hasegawa, Tatuya Morimoto

引用次数: 0

Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay. 通过高通量筛选实验发现用于培养心肌细胞治疗心力衰竭的新型小分子。

IF 3

European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO10

Satoshi Shimizu, Miho Yamada, Takahiro Katagiri, Yoichi Sunagawa, Yasufumi Katanasaka, Yusuke Miyazaki, Masafumi Funamoto, Sari Nurmila, Kana Shimizu, Naohisa Ogo, Akira Asai, Koji Hasegawa, Tatsuya Morimoto

引用次数: 0

Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. 经皮冠状动脉介入治疗冠心病患者CYP2C19基因多态性的研究

IF 3

European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO5

Maya Rosana Amalia, Susi Herminingsih

引用次数: 0

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats. 一种新的姜黄素制剂ASD-Cur抑制大鼠心肌梗死后收缩功能障碍的发展。

IF 3

European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO13

Hidemichi Takai, Yoichi Sunagawa, Masafumi Funamoto, Kana Shimizu, Satoshi Shimizu, Yasufumi Katanasaka, Yusuke Miyazaki, Atsusi Imaizumi, Tadashi Hashimoto, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto

引用次数: 0

Neuromodulatory Approaches for Atrial Fibrillation Ablation. 心房颤动消融的神经调节入路。

IF 3

European cardiology Pub Date : 2021-12-09 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.05

Moisés Rodríguez-Mañero, Jose Luis Martínez-Sande, Javier García-Seara, Teba González-Ferrero, José Ramón González-Juanatey, Paul Schurmann, Liliana Tavares, Miguel Valderrábano

引用次数: 1

Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia. 亚太心脏病学会关于血脂异常的共识建议。

IF 3

European cardiology Pub Date : 2021-12-09 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.36

Natalie Koh, Brian A Ference, Stephen J Nicholls, Ann Marie Navar, Derek P Chew, Karam Kostner, Ben He, Hung Fat Tse, Jamshed Dalal, Anwar Santoso, Junya Ako, Hayato Tada, Jin Joo Park, Mei Lin Ong, Eric Lim, Tavin Subramaniam, Yi-Heng Li, Arintaya Phrommintikul, S S Iyengar, Saumitra Ray, Kyung Woo Park, Hong Chang Tan, Narathip Chunhamaneewat, Khung Keong Yeo, Jack Wei Chieh Tan

{"title":"Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia.","authors":"Natalie Koh, Brian A Ference, Stephen J Nicholls, Ann Marie Navar, Derek P Chew, Karam Kostner, Ben He, Hung Fat Tse, Jamshed Dalal, Anwar Santoso, Junya Ako, Hayato Tada, Jin Joo Park, Mei Lin Ong, Eric Lim, Tavin Subramaniam, Yi-Heng Li, Arintaya Phrommintikul, S S Iyengar, Saumitra Ray, Kyung Woo Park, Hong Chang Tan, Narathip Chunhamaneewat, Khung Keong Yeo, Jack Wei Chieh Tan","doi":"10.15420/ecr.2021.36","DOIUrl":"https://doi.org/10.15420/ecr.2021.36","url":null,"abstract":"The prevalence of dyslipidaemia has been increasing in the Asia-Pacific region and this is attributed to dietary changes and decreasing physical activity. While there has been substantial progress in dyslipidaemia therapy, its management in the region is hindered by limitations in awareness, adherence and healthcare costs. The Asian Pacific Society of Cardiology (APSC) developed these consensus recommendations to address the need for a unified approach to managing dyslipidaemia. These recommendations are intended to guide general cardiologists and internists in the assessment and treatment of dyslipidaemia and are hoped to pave the way for improving screening, early diagnosis and treatment. The APSC expert panel reviewed and appraised the evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Consensus recommendations were developed, which were then put to an online vote. The resulting consensus recommendations tackle contemporary issues in the management of dyslipidaemia, familial hypercholesterolaemia and lipoprotein(a) in the Asia-Pacific region.","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e54"},"PeriodicalIF":3.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/36/ecr-16-e54.PMC8728885.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39678467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Why We Need Specialised Centres for Women's Hearts: Changing the Face of Cardiovascular Care for Women. 为什么我们需要专门的妇女心脏中心:改变妇女心血管护理的面貌。

IF 3

European cardiology Pub Date : 2021-12-09 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.49

Martha Gulati, Cara Hendry, Biljana Parapid, Sharon L Mulvagh

{"title":"Why We Need Specialised Centres for Women's Hearts: Changing the Face of Cardiovascular Care for Women.","authors":"Martha Gulati, Cara Hendry, Biljana Parapid, Sharon L Mulvagh","doi":"10.15420/ecr.2021.49","DOIUrl":"https://doi.org/10.15420/ecr.2021.49","url":null,"abstract":"Although cardiovascular disease (CVD) is the leading cause of mortality in women globally, cardiovascular care for women remains suboptimal, with poorer outcomes than for men. During the past two decades, there has been an incremental increase in research and publications on CVD in women, addressing sex-specific risk factors, symptoms, pathophysiology, treatment, prevention and identification of inequities in care. Nonetheless, once women have manifested CVD, they continue to have increasingly worse outcomes than men. An approach to addressing these global disparities has been the worldwide establishment of specialised centres providing cardiovascular care for women. These women's heart centres (WHCs) allow a comprehensive approach to the cardiovascular care of women across the lifespan. The purpose of this article is to define the need for and role of these specialised centres by outlining sex-specific gaps in CVD care, and to provide guidance on components within WHCs that may be considered when establishing such programmes.","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e52"},"PeriodicalIF":3.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/c4/ecr-16-e52.PMC8728884.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39818179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 8

Relationship Between Exposure to Sulphur Dioxide Air Pollution, White Cell Inflammatory Biomarkers and Enzymatic Infarct Size in Patients With ST-segment Elevation Acute Coronary Syndromes. st段抬高急性冠状动脉综合征患者暴露于二氧化硫空气污染、白细胞炎症生物标志物和酶促梗死大小的关系

IF 3

European cardiology Pub Date : 2021-12-07 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.37

Laura Díaz-Chirón, Luis Negral, Laura Megido, Beatriz Suárez-Peña, Alberto Domínguez-Rodríguez, Sergio Rodríguez, Pedro Abreu-Gonzalez, Isaac Pascual, César Moris, Pablo Avanzas

{"title":"Relationship Between Exposure to Sulphur Dioxide Air Pollution, White Cell Inflammatory Biomarkers and Enzymatic Infarct Size in Patients With ST-segment Elevation Acute Coronary Syndromes.","authors":"Laura Díaz-Chirón, Luis Negral, Laura Megido, Beatriz Suárez-Peña, Alberto Domínguez-Rodríguez, Sergio Rodríguez, Pedro Abreu-Gonzalez, Isaac Pascual, César Moris, Pablo Avanzas","doi":"10.15420/ecr.2021.37","DOIUrl":"https://doi.org/10.15420/ecr.2021.37","url":null,"abstract":"Aims: To analyse the relationship among air pollutants, markers of inflammation and infarct size in patients with acute coronary syndrome (ACS). Methods: This was a prospective analysis of consecutive patients admitted to hospital because of ACS. Cardiac biomarkers were drawn. The daily mean values of the air pollutants from the day before until 7 days before admission were analysed. The study population was stratified according to infarct size, based on median peak troponin value. Results: Patients were divided into two groups of 108 subjects each, according to median peak troponin value. Patients with extensive MIs had a higher neutrophil:lymphocyte ratio and leukocyte and neutrophil counts than patients with smaller MIs. In addition, they were exposed to higher concentrations of sulphur dioxide (9.7 ± 4.1 versus 8.4 ± 3.1 μg/m3; p=0.009) and lower concentrations of ozone (33.8 ± 13.7 versus 38.6 ± 14.5 μg/m3; p=0.014). Multivariate analysis showed that sulphur dioxide levels (OR 1.12; 95% CI [1.031-1.21]; p=0.007) and neutrophil/lymphocyte ratio (OR 1.08; 95% CI [1.011-1.17]; p=0.024) were independent predictors of infarct size. Conclusion: Patients with extensive MIs had higher white cell inflammatory levels and had been exposed to higher sulphur dioxide concentrations in the ambient air.","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e50"},"PeriodicalIF":3.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/11/ecr-16-e50.PMC8674636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39847480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart-Kidney Team-Based Approach. 慢性肾脏疾病中的冠状动脉疾病:需要以心脏-肾脏团队为基础的方法。

IF 3

European cardiology Pub Date : 2021-12-07 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.30

Gautam R Shroff, Michelle D Carlson, Roy O Mathew

引用次数: 3

Definitions and Epidemiology of Coronary Functional Abnormalities. 冠状动脉功能异常的定义和流行病学。

IF 3

European cardiology Pub Date : 2021-12-07 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.14

Andreas Seitz, Johanna McChord, Raffi Bekeredjian, Udo Sechtem, Peter Ong

{"title":"Definitions and Epidemiology of Coronary Functional Abnormalities.","authors":"Andreas Seitz, Johanna McChord, Raffi Bekeredjian, Udo Sechtem, Peter Ong","doi":"10.15420/ecr.2021.14","DOIUrl":"https://doi.org/10.15420/ecr.2021.14","url":null,"abstract":"Coronary functional abnormalities are frequent causes of angina pectoris, particularly in patients with unobstructed coronary arteries. There is a spectrum of endotypes of functional coronary abnormalities with different mechanisms of pathology including enhanced vasoconstriction (i.e. coronary artery spasm) or impaired vasodilatation, such as impaired coronary flow reserve or increased microvascular resistance. These vasomotor abnormalities can affect various compartments of the coronary circulation such as the epicardial conduit arteries and/or the coronary microcirculation. Unequivocal categorisation and nomenclature of the broad spectrum of disease endotypes is crucial both in clinical practice as well as in clinical trials. This article describes the definitions of coronary functional abnormalities with currently accepted cut-off values, as well as diagnostic methods to identify and distinguish endotypes. The authors also provide a summary of contemporary data on the prevalence of the different endotypes of coronary functional abnormalities and their coexistence.","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e51"},"PeriodicalIF":3.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/f0/ecr-16-e51.PMC8674628.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39847481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2